Nissan Medical Industries Ltd (TLV:NISA)
Israel · Delayed Price · Currency is ILS · Price in ILA 706.30
-28.70 (-3.90%)
Jun 4, 2026, 5:24 PM IDT
Nissan Medical Industries Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4.17 | 7.91 | 5.65 | -36.05 | 36.01 |
Depreciation & Amortization | 27.8 | 29.64 | 31.14 | 28.65 | 25.6 |
Loss (Gain) From Sale of Assets | - | - | 0.2 | -0.04 | 0.07 |
Asset Writedown & Restructuring Costs | - | - | - | 23.79 | - |
Loss (Gain) From Sale of Investments | -0.13 | -0.01 | -0.01 | 0.05 | -5.39 |
Loss (Gain) on Equity Investments | -0.18 | -1.3 | 7.06 | 0.64 | -4.62 |
Stock-Based Compensation | 0.47 | 1.18 | 0.58 | 0.27 | 1.45 |
Other Operating Activities | 15.17 | 17.07 | 34.08 | 3.61 | 25.89 |
Change in Accounts Receivable | -8.48 | 20.61 | 33.8 | -19.71 | -16.45 |
Change in Inventory | 42.41 | -54.41 | -6.07 | 8.41 | -52 |
Change in Accounts Payable | -19.04 | 7.08 | -7.41 | 5.29 | 12.21 |
Change in Other Net Operating Assets | 0.45 | -0.94 | 6.69 | -3.22 | -4.8 |
Operating Cash Flow | 62.64 | 26.83 | 105.72 | 11.67 | 17.98 |
Operating Cash Flow Growth | 133.44% | -74.62% | 805.56% | -35.07% | -85.33% |
Capital Expenditures | -26.11 | -6.09 | -9.82 | -9.18 | -8.16 |
Sale of Property, Plant & Equipment | 0.06 | 0.03 | 0.26 | 0.17 | 0.03 |
Sale (Purchase) of Intangibles | -0.02 | -0.21 | -0.36 | -0.51 | -0.14 |
Investment in Securities | 1.7 | 13.79 | - | -0.15 | 8.42 |
Other Investing Activities | 10.66 | -11.39 | - | - | 5.48 |
Investing Cash Flow | -13.71 | -3.87 | -9.93 | -9.68 | 5.62 |
Short-Term Debt Issued | 10.25 | 23.92 | 7.32 | 13.37 | - |
Long-Term Debt Issued | 55.72 | 49.11 | - | 42.71 | 89.91 |
Total Debt Issued | 65.97 | 73.03 | 7.32 | 56.08 | 89.91 |
Short-Term Debt Repaid | - | -0.5 | - | - | -3.42 |
Long-Term Debt Repaid | -81.84 | -74.91 | -73.67 | -66.82 | -80.87 |
Total Debt Repaid | -81.84 | -75.41 | -73.67 | -66.82 | -84.29 |
Net Debt Issued (Repaid) | -15.87 | -2.38 | -66.35 | -10.75 | 5.61 |
Common Dividends Paid | -16.53 | -6.81 | - | -4 | -9.08 |
Other Financing Activities | -12.32 | -23.18 | -24.36 | -11.04 | -27.73 |
Financing Cash Flow | -44.72 | -32.37 | -90.71 | -25.78 | -31.2 |
Foreign Exchange Rate Adjustments | -2.23 | 0.26 | 0.46 | 3.03 | -0.88 |
Net Cash Flow | 1.99 | -9.14 | 5.53 | -20.75 | -8.48 |
Free Cash Flow | 36.53 | 20.74 | 95.9 | 2.49 | 9.82 |
Free Cash Flow Growth | 76.09% | -78.37% | 3745.07% | -74.60% | -90.97% |
Free Cash Flow Margin | 5.60% | 3.12% | 13.07% | 0.36% | 1.47% |
Free Cash Flow Per Share | 4.02 | 2.28 | 10.56 | 0.28 | 1.08 |
Cash Interest Paid | 12.32 | 13.79 | 16.31 | 11.04 | 10.11 |
Cash Income Tax Paid | 2.99 | 6.29 | 9.3 | 2.34 | 11.64 |
Levered Free Cash Flow | 45.74 | 5.89 | 54.04 | -4.51 | -1.37 |
Unlevered Free Cash Flow | 53.24 | 14.23 | 67.33 | 1.75 | 3.18 |
Change in Working Capital | 15.33 | -27.65 | 27.02 | -9.24 | -61.03 |